Analysis Egetis Therapeutics AB (0ABW)
5/30/2024
Analysis of Egetis Therapeutics AB (0ABW)
Egetis Therapeutics AB (0ABW) has shown some interesting price movements and technical indicators in the recent trading days:1. Price Movement:
- The closing price has been fluctuating between 6.61 and 8.4 in the past few days, showing some volatility in the stock.
- The stock closed at 4.77 on the latest available date, indicating a potential increase in price in the following days.
2. Technical Indicators:
- RSI Indicator: The Relative Strength Index (RSI) values have been above 50, indicating bullish momentum in the stock.
- MACD Indicator: The Moving Average Convergence Divergence (MACD) values have been positive, suggesting a bullish trend.
- Moving Averages: The Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) have been trending upwards, supporting a bullish outlook.
Overall, based on the technical indicators and recent price movements, Egetis Therapeutics AB (0ABW) appears to have a bullish sentiment in the short term. However, it is essential to consider other factors and conduct further analysis before making any investment decisions.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The results for the quarter ending on January 31, 2025, were released after hours. The results for the quarter ending on October 31, 2024, were not provided at this time. The results for the quarter ending on August 1, 2024, showed an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has a strong operating cash flow and levered free cash flow. The balance sheet shows a healthy current ratio, but a relatively high total debt to equity ratio. The profit margin and operating margin are both positive, indicating profitability. The company's fiscal year ends in September 2023, with notable figures such as revenue, EBITDA, and net income.
Moving on to stock statistics, key metrics include short ratio, float shares, shares outstanding, and insider and institutional ownership percentages. The company's stock price summary provides information on beta, moving averages, and the range of stock prices over the past year.
Valuation metrics show ratios such as PEG ratio, PE ratios, price to book, price to sales, and enterprise value multiples. The market capitalization is also provided.
Lastly, dividends and splits data include payout ratio, dividend dates, split history, and dividend yield information. The company has a dividend payment history and a current dividend yield.
Income statement 💸
These are the revenues. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the past four fiscal years.
2. The gross profit margin seems to be relatively stable, with fluctuations in cost of goods sold.
3. Earnings before interest and taxes (EBIT) have shown an increasing trend, indicating improved operational efficiency.
4. Net income has also been on the rise, showing that the company is effectively managing its expenses and taxes.
5. Earnings per share (EPS) have generally increased over the years, reflecting growth in profitability.
6. The company has been able to maintain a consistent number of outstanding shares.
7. Overall, the financial performance of the company seems to be positive and improving over the years.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.33, which is higher than the EPS of $1.26 from the same quarter a year ago. The range of estimates is between $1.27 and $1.36, as provided by 26 analysts.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.53, compared to $1.46 from the previous year. The estimates range from $1.44 to $1.63, based on 25 analysts' forecasts.
3. Looking at the estimates for the current fiscal year ending on September 30, 2024, the average EPS is projected to be $6.59, an increase from the previous year's EPS of $6.13. The low estimate is $6.43, while the high estimate is $6.92, with insights provided by 39 analysts.
4. For the next fiscal year ending on September 30, 2025, analysts anticipate further growth in earnings per share, with an average estimate of $7.23. This forecast falls within a range of $6.40 to $7.90, as predicted by 39 analysts.
Overall, the analysts' estimates suggest a positive outlook for the company's earnings per share, showing growth both in the short term and the long term.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided:- The company is expected to experience a growth rate of 7.5% in the current year and 9.7% in the next year.
- For the current quarter, the growth rate is estimated to be 5.6%, while for the next quarter it is projected to be 4.8%.
- Over the next 5 years, the company is expected to achieve an average annual growth rate of 11%.
- However, in the past 5 years, the company has experienced a higher average annual growth rate of approximately 20.1%.
Overall, the company is expected to maintain a positive growth trajectory, with a slightly lower growth rate in the short term compared to the long-term average.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security, with a median forecast of $200. However, there is a wide range of forecasts, from a low of $164 to a high of $250. The current price of the security is $191.57.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets include cash, inventory, and receivables, with a significant portion in cash equivalents and short-term investments.
3. Non-current assets consist mainly of investments and advances, along with machinery, furniture, and equipment.
4. Total liabilities have also been increasing, but at a slower pace compared to assets.
5. Shareholders' equity has shown a positive trend, indicating a healthy financial position.
6. The company has been investing in leases, land, and improvements, while also managing debt levels effectively.
7. Overall, the financial health of the company seems stable and improving over the years.
Cash Flow 💶
This is a cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. Financing activities show significant changes, with fluctuations in common stock repurchases, debt issuances, and dividends.
5. Investing activities also vary, with notable amounts spent on acquisitions, investments, and capital expenditures.
6. The end cash position has been fluctuating, reaching its highest value in 2020 and its lowest in 2022.
These conclusions provide insights into the company's financial performance and management of cash flows over the years.
MACD of 0ABW
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
